November 16, 2023 (PR Newswire)
Cellecta, Inc. today announced the launch of the DriverMap™ Adaptive Immune Receptor (AIR) Mouse RNA TCR and BCR kits. These new Mouse AIR assays supplement the line of multiplex-PCR, NGS-based T- and B-cell Receptor assays and, like Cellecta’s current kits targeting human T- and B-cells, enable profiling of all seven T-cell receptor (TCR) and B-cell receptor (BCR) chains in a single reaction without need of specialized equipment.
October 9, 2023 (PR Newswire)
Cellecta, Inc. today announced the release of new pooled, single-module, CRISPR genome-wide knockout libraries for chicken (Gallus gallus) and pig (Sus scrofa). The new libraries will allow the study of gene disruptions in a single experiment to enable improved breeding and more.
April 12, 2023 (PR Newswire)
Cellecta, Inc. today announced the launch of the DriverMap™ Adaptive Immune Receptor DNA (AIR-DNA) TCR and BCR kits which provide rapid, single-tube PCR-based assays to analyze the genomic diversity of receptors from T-cells or B-cells from a wide range of immune sample types, including whole blood, tissue biopsies, FFPE and more.
November 10, 2022 (PR Newswire)
The Cureline Group and Cellecta, Inc. today announced the launch of Tissue 2 Target™, a new strategic partnership to combine the companies' core strengths in human biospecimen (HBS) management and molecular analysis of cells and tissues to streamline workflows for pre-clinical and translational research laboratories.
October 5, 2022 (PR Newswire)
Cellecta, Inc. today announced the launch of the DriverMap™ Adaptive Immune Receptor (AIR) RNA TCR and BCR kits, a family of multiplex-PCR, NGS-based assays that enable profiling of up to all seven T-cell receptor (TCR) and B-cell receptor (BCR) chains from the same sample, in a single tube, without need of specialized equipment.
October 5, 2021
MilliporeSigma's Life Science Business Sector announced the signing of a licensing agreement for its CRISPR-mediated knock-in technology with Cellecta, Inc.
November 5, 2020 (PR Newswire)
Cellecta today announced the launch of its new RNA Spatial Profiling Service using NanoString’s GeoMx® Cancer Transcriptome Atlas (CTA) on the GeoMx Digital Spatial Profiler.
CELLECTA, Inc. Launches the First Commercially Available Dual-sgRNA Libraries for CRISPRa and CRISPRi Genetic Screens
June 26, 2019 (PR Newswire)
Cellecta today announced the launch of the first commercially available dual sg-RNA libraries designed for CRISPR activation and CRISPR interference genetic screens. These new pooled libraries enhance activation or repression of genes producing more robust results from genetic screens.